Hydrochlorothiazide and the risk of skin cancer. A scientific statement of the British and Irish Hypertension Society

Source:
British and Irish Hypertension Society - BIHS
Publisher:
British and Irish Hypertension Society (BIHS)
Publication date:
06 March 2019

Abstract

This statement from BIHS adresses concerns raised by a recent series of articles from various Danish nationwide demographic and health registries which have associated the anti-hypertensive drug Hydrochlorothiazide (HCTZ) use with increased risk of lip and skin cancer. This finding has received much publicity and has caused concerns amongst physicians, and their patients.